Christopher L. Carpenter

Christopher L. Carpenter

Palliative Medicine
501 W 14th St
Wilmington, DE 19801

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

Journal: The Lancet. Oncology
Published: July 02, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026